Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Disease Progression, Treatment Effectiveness, and Co-Morbid Burden Among Adult Patients with Primary Immune Thrombocytopenia (ITP): Results From the United Kingdom Registry.

Ameet Sarpatwari, M.Phil, Dimitri Bennett, MD, MPH, Adrian Newland, MD, FRCP, Simon Sanderson, MD, Drew Provan, MD

Blood (2009) 114 (22): 4457.

https://doi.org/10.1182/blood.V114.22.4457.4457

Published: 2009

Journal Articles

Long-Term Efficacy and Safety of Romiplostim for the Treatment of Patients with Chronic Immune Thrombocytopenia (ITP): 5-Year Update From An Open-Label Extension Study.

James B. Bussel, MD, David J Kuter, MD, DPhil, Adrian Newland, MD, FRCP, Joost TM de Wolf, MD, Jeffrey Wasser, MD, Paul Chang, Kun Nie, Dietmar Berger, MD, PhD

Blood (2009) 114 (22): 681.

https://doi.org/10.1182/blood.V114.22.681.681

Published: 2009

Journal Articles

Autologous 111 In-Labeled Platelet Sequestration Studies in Patients with Primary Immune Thrombocytopenia (ITP): A Report From the United Kingdom Registry.

Ameet Sarpatwari, M.Phil, Drew Provan, MD, Ravin Sobnack, PhD, Sebhat Erqou, MD, M.Phil, F. W. David Tai, BSc., Simon Sanderson, MD, Adrian Newland, MD, FRCP

Blood (2009) 114 (22): 2406.

https://doi.org/10.1182/blood.V114.22.2406.2406

Published: 2009

Journal Articles

Health-Related Lifestyle among Adult & Pediatric Patients with Idiopathic Thrombocytopenic Purpura in the United Kingdom.

Ameet Sarpatwari, MPhil, Shirley Watson, Howard Anderson, Drew Provan, MD, Adrian Newland, MD, FRCP

Blood (2008) 112 (11): 3435.

https://doi.org/10.1182/blood.V112.11.3435.3435

Published: 2008

Journal Articles

Thromboembolic Events among Adult Patients with Idiopathic Thrombocytopenic Purpura in the United Kingdom General Practice Research Database.

Ameet Sarpatwari, MPhil, Dimitri Bennett, MD, MPH, John W Logie, PhD, Amit Shukla, BSc, Kathleen J Beach, MD, MPH, Adrian Newland, MD, FRCP, Simon Sanderson, MD, Drew Provan, MD

Blood (2008) 112 (11): 3401.

https://doi.org/10.1182/blood.V112.11.3401.3401

Published: 2008

Journal Articles

Long-Term Treatment with Romiplostim in Patients with Chronic Immune Thrombocytopenic Purpura (ITP): 3-Year Update from An Open-Label Extension Study

David J Kuter, MD, DPhil, James B Bussel, MD, Adrian Newland, MD, FRCP, Joost TM de Wolf, MD, Troy Guthrie, MD, Jeffrey Wasser, MD, Lara Gehl, Kun Nie, PhD, Dietmar Berger, MD, PhD

Blood (2008) 112 (11): 402.

https://doi.org/10.1182/blood.V112.11.402.402

Published: 2008

Journal Articles

Using CD160 as a Novel Approach to the Assessment of Minimal Residual Disease (MRD) in Chronic Lymphocytic Leukaemia (CLL).

Timothy Farren, BSc (Hons), Jerome Giustiniani, PhD, Ulrika Johansson, PhD, Christina Lim, RN, Gemma Athorn, MSc, Adrian Newland, MD, Marion Macey, PhD, Samir Agrawal, MD, PhD

Blood (2007) 110 (11): 2036.

https://doi.org/10.1182/blood.V110.11.2036.2036

Published: 2007

Journal Articles

An Open Label, Multi Center Study on the Efficacy and Safety of a Liquid, Ready-to-Use Intravenously Administered Anti-D Immunoglobulin in Patients with Chronic Immune Thrombocytopenic Purpura.

Louis M. Aledort, MD, Abdulgabar Salama, MD, Lidia Kovaleva, MD, Tadeusz Robak, MD, Benjamin Brenner, MD, Adrian Newland, MD, Simon Davies, MD, Diane J. Nugent, MD, Alphonse Hubsch, DVM, Irmgard Andresen, MD, Othmar Zenker, MD

Blood (2004) 104 (11): 3943.

https://doi.org/10.1182/blood.V104.11.3943.3943

Published: 2004

Journal Articles

An Open-Label, Unit Dose-Finding Study Evaluating the Safety and Platelet Response of a Novel Thrombopoietic Protein (AMG531) in Thrombocytopenic Adult Patients (Pts) with Immune Thrombocytopenic Purpura (ITP).

Adrian Newland, MD, Marie T. Caulier, MD, Martin R. Schipperus, MD, Maria Kappers-Klunne, MD, Bruno R. Varet, Karen Watkins, BA, Chien-Feng Chen, PhD, Janet L. Nichol, MS

Blood (2004) 104 (11): 2058.

https://doi.org/10.1182/blood.V104.11.2058.2058

Published: 2004

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Disease Progression, Treatment Effectiveness, and Co-Morbid Burden Among Adult Patients with Primary Immune Thrombocytopenia (ITP): Results From the United Kingdom Registry.

Long-Term Efficacy and Safety of Romiplostim for the Treatment of Patients with Chronic Immune Thrombocytopenia (ITP): 5-Year Update From An Open-Label Extension Study.

Autologous 111 In-Labeled Platelet Sequestration Studies in Patients with Primary Immune Thrombocytopenia (ITP): A Report From the United Kingdom Registry.

Health-Related Lifestyle among Adult & Pediatric Patients with Idiopathic Thrombocytopenic Purpura in the United Kingdom.

Thromboembolic Events among Adult Patients with Idiopathic Thrombocytopenic Purpura in the United Kingdom General Practice Research Database.

Long-Term Treatment with Romiplostim in Patients with Chronic Immune Thrombocytopenic Purpura (ITP): 3-Year Update from An Open-Label Extension Study

Using CD160 as a Novel Approach to the Assessment of Minimal Residual Disease (MRD) in Chronic Lymphocytic Leukaemia (CLL).

An Open Label, Multi Center Study on the Efficacy and Safety of a Liquid, Ready-to-Use Intravenously Administered Anti-D Immunoglobulin in Patients with Chronic Immune Thrombocytopenic Purpura.

An Open-Label, Unit Dose-Finding Study Evaluating the Safety and Platelet Response of a Novel Thrombopoietic Protein (AMG531) in Thrombocytopenic Adult Patients (Pts) with Immune Thrombocytopenic Purpura (ITP).

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only